<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the prevalence of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> in patients with the slowly progressing autoimmune form of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, also referred to as latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> in adults (LADA) </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We evaluated factors associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> in 59 patients with GAD antibodies (GADAs) and age at <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp> &gt;35 years and in 59 GADA-negative type 2 diabetic patients </plain></SENT>
<SENT sid="2" pm="."><plain>The prevalence of <z:hpo ids='HP_0011010'>chronic</z:hpo> complications was further compared with the prevalence in 111 type 1 diabetic patients </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The LADA patients had lower BMI (P = 0.04), waist-to-hip ratio (P = 0.02 for men and P = 0.03 for women), and fasting C-<z:chebi fb="7" ids="16670">peptide</z:chebi> concentrations (P&lt;0.001) higher HDL2 concentrations (P = 0.04), and less <z:hpo ids='HP_0000822'>hypertension</z:hpo> (58 vs. 75%, P = 0.05) than the type 2 diabetic patients </plain></SENT>
<SENT sid="4" pm="."><plain>These differences were even more marked in patients with short disease duration </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (51 vs. 56%), <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> (29 vs. 27%), and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (27 vs. 29%) did not differ between the groups </plain></SENT>
<SENT sid="6" pm="."><plain>The type 1 diabetic patients had lower prevalence of <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> (13%, P = 0.02) and higher prevalence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (76%, P = 0.002) compared with the other groups </plain></SENT>
<SENT sid="7" pm="."><plain>Neither the prevalence of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (CHD) (56 vs. 58%) nor cardiovascular mortality (7.4 vs. 12.4%, P = 0.2) significantly differed between the LADA and type 2 diabetic patients </plain></SENT>
<SENT sid="8" pm="."><plain>In a multiple logistic regression analysis, glycemic control was associated with CHD (P = 0.02) in the LADA group but not in the type 2 diabetic group </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Glycemic control is a stronger risk factor for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> in LADA patients than in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>This could be related to the lower prevalence of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> seen in the former </plain></SENT>
</text></document>